EMEA (Europe, Middle East and Africa) Human Somatotropin Market Report 2017

January 2018 | 116 pages | ID: EEEDC88EA4BEN
QYResearch

Abstracts

In this report, the EMEA Human Somatotropin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Human Somatotropin for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Human Somatotropin market competition by top manufacturers/players, with Human Somatotropin sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novo Nordisk
• Pfizer
• Eli Lilly
• Merck Serono
• F. Hoffmann-La Roche
• Ferring Pharmaceuticals
• GeneScience Pharmaceuticals
• Ipsen
• LG Life Sciences
• Sandoz International
• Anhui Anke Biotechnology

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Powder
• Solvent

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Growth Hormone Deficiency (GHD)
• Turner Syndrome
• Chronic Renal Insufficiency
• Prader Willi Syndrome
• Small for Gestational Age
• SHOX Deficiency
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Human Somatotropin Market Report 2017

1 HUMAN SOMATOTROPIN OVERVIEW

1.1 Product Overview and Scope of Human Somatotropin
1.2 Classification of Human Somatotropin
  1.2.1 EMEA Human Somatotropin Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Human Somatotropin Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Powder
  1.2.4 Solvent
1.3 EMEA Human Somatotropin Market by Application/End Users
  1.3.1 EMEA Human Somatotropin Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Growth Hormone Deficiency (GHD)
  1.3.3 Turner Syndrome
  1.3.4 Chronic Renal Insufficiency
  1.3.5 Prader Willi Syndrome
  1.3.6 Small for Gestational Age
  1.3.7 SHOX Deficiency
  1.3.8 Others
1.4 EMEA Human Somatotropin Market by Region
  1.4.1 EMEA Human Somatotropin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Human Somatotropin (2012-2022)
  1.5.1 EMEA Human Somatotropin Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Human Somatotropin Revenue and Growth Rate (2012-2022)

2 EMEA HUMAN SOMATOTROPIN COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Human Somatotropin Market Competition by Players/Manufacturers
  2.1.1 EMEA Human Somatotropin Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Human Somatotropin Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Human Somatotropin Sale Price by Players (2012-2017)
2.2 EMEA Human Somatotropin (Volume and Value) by Type/Product Category
  2.2.1 EMEA Human Somatotropin Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Human Somatotropin Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Human Somatotropin Sale Price by Type (2012-2017)
2.3 EMEA Human Somatotropin (Volume) by Application
2.4 EMEA Human Somatotropin (Volume and Value) by Region
  2.4.1 EMEA Human Somatotropin Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Human Somatotropin Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Human Somatotropin Sales Price by Region (2012-2017)

3 EUROPE HUMAN SOMATOTROPIN (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Human Somatotropin Sales and Value (2012-2017)
  3.1.1 Europe Human Somatotropin Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Human Somatotropin Revenue and Growth Rate (2012-2017)
3.2 Europe Human Somatotropin Sales and Market Share by Type
3.3 Europe Human Somatotropin Sales and Market Share by Application
3.4 Europe Human Somatotropin Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Human Somatotropin Sales Volume by Countries (2012-2017)
  3.4.2 Europe Human Somatotropin Revenue by Countries (2012-2017)
  3.4.3 Germany Human Somatotropin Sales and Growth Rate (2012-2017)
  3.4.4 France Human Somatotropin Sales and Growth Rate (2012-2017)
  3.4.5 UK Human Somatotropin Sales and Growth Rate (2012-2017)
  3.4.6 Russia Human Somatotropin Sales and Growth Rate (2012-2017)
  3.4.7 Italy Human Somatotropin Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Human Somatotropin Sales and Growth Rate (2012-2017)

4 MIDDLE EAST HUMAN SOMATOTROPIN (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Human Somatotropin Sales and Value (2012-2017)
  4.1.1 Middle East Human Somatotropin Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Human Somatotropin Revenue and Growth Rate (2012-2017)
4.2 Middle East Human Somatotropin Sales and Market Share by Type
4.3 Middle East Human Somatotropin Sales and Market Share by Application
4.4 Middle East Human Somatotropin Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Human Somatotropin Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Human Somatotropin Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Human Somatotropin Sales and Growth Rate (2012-2017)
  4.4.4 Israel Human Somatotropin Sales and Growth Rate (2012-2017)
  4.4.5 UAE Human Somatotropin Sales and Growth Rate (2012-2017)
  4.4.6 Iran Human Somatotropin Sales and Growth Rate (2012-2017)

5 AFRICA HUMAN SOMATOTROPIN (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Human Somatotropin Sales and Value (2012-2017)
  5.1.1 Africa Human Somatotropin Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Human Somatotropin Revenue and Growth Rate (2012-2017)
5.2 Africa Human Somatotropin Sales and Market Share by Type
5.3 Africa Human Somatotropin Sales and Market Share by Application
5.4 Africa Human Somatotropin Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Human Somatotropin Sales Volume by Countries (2012-2017)
  5.4.2 Africa Human Somatotropin Revenue by Countries (2012-2017)
  5.4.3 South Africa Human Somatotropin Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Human Somatotropin Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Human Somatotropin Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Human Somatotropin Sales and Growth Rate (2012-2017)

6 EMEA HUMAN SOMATOTROPIN MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Novo Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Somatotropin Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novo Nordisk Human Somatotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Human Somatotropin Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Human Somatotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Human Somatotropin Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly Human Somatotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck Serono
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Human Somatotropin Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck Serono Human Somatotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 F. Hoffmann-La Roche
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Human Somatotropin Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 F. Hoffmann-La Roche Human Somatotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Ferring Pharmaceuticals
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Human Somatotropin Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Ferring Pharmaceuticals Human Somatotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 GeneScience Pharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Human Somatotropin Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GeneScience Pharmaceuticals Human Somatotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Ipsen
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Human Somatotropin Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Ipsen Human Somatotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 LG Life Sciences
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Human Somatotropin Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 LG Life Sciences Human Somatotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Sandoz International
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Human Somatotropin Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Sandoz International Human Somatotropin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Anhui Anke Biotechnology

7 HUMAN SOMATOTROPIN MANUFACTURING COST ANALYSIS

7.1 Human Somatotropin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Somatotropin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Somatotropin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Somatotropin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA HUMAN SOMATOTROPIN MARKET FORECAST (2017-2022)

11.1 EMEA Human Somatotropin Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Human Somatotropin Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Human Somatotropin Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Human Somatotropin Price and Trend Forecast (2017-2022)
11.2 EMEA Human Somatotropin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Human Somatotropin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Human Somatotropin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Human Somatotropin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Human Somatotropin Sales Forecast by Type (2017-2022)
11.7 EMEA Human Somatotropin Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Somatotropin
Figure EMEA Human Somatotropin Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Human Somatotropin Sales Volume Market Share by Type (Product Category) in 2016
Figure Powder Product Picture
Figure Solvent Product Picture
Figure EMEA Human Somatotropin Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Human Somatotropin by Application in 2016
Figure Growth Hormone Deficiency (GHD) Examples
Table Key Downstream Customer in Growth Hormone Deficiency (GHD)
Figure Turner Syndrome Examples
Table Key Downstream Customer in Turner Syndrome
Figure Chronic Renal Insufficiency Examples
Table Key Downstream Customer in Chronic Renal Insufficiency
Figure Prader Willi Syndrome Examples
Table Key Downstream Customer in Prader Willi Syndrome
Figure Small for Gestational Age Examples
Table Key Downstream Customer in Small for Gestational Age
Figure SHOX Deficiency Examples
Table Key Downstream Customer in SHOX Deficiency
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Human Somatotropin Market Size (Million USD) by Region (2012-2022)
Figure Europe Human Somatotropin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Human Somatotropin Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Human Somatotropin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Human Somatotropin Revenue (Million USD) Status and Forecast by Countries
Figure Africa Human Somatotropin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Human Somatotropin Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Human Somatotropin Sales Volume and Growth Rate (2012-2022)
Figure EMEA Human Somatotropin Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Human Somatotropin Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Human Somatotropin Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Human Somatotropin Sales Share by Players (2012-2017)
Figure 2016 Human Somatotropin Sales Share by Players
Figure 2017 Human Somatotropin Sales Share by Players
Figure EMEA Human Somatotropin Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Human Somatotropin Revenue (Million USD) by Players (2012-2017)
Table EMEA Human Somatotropin Revenue Share by Players (2012-2017)
Table 2016 EMEA Human Somatotropin Revenue Share by Players
Table 2017 EMEA Human Somatotropin Revenue Share by Players
Table EMEA Human Somatotropin Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Human Somatotropin Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Human Somatotropin Sales Share by Type (2012-2017)
Figure Sales Market Share of Human Somatotropin by Type (2012-2017)
Figure EMEA Human Somatotropin Sales Market Share by Type (2012-2017)
Table EMEA Human Somatotropin Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Human Somatotropin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Somatotropin by Type in 2016
Table EMEA Human Somatotropin Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Human Somatotropin Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Human Somatotropin Sales Share by Application (2012-2017)
Figure Sales Market Share of Human Somatotropin by Application (2012-2017)
Figure EMEA Human Somatotropin Sales Market Share by Application in 2016
Table EMEA Human Somatotropin Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Human Somatotropin Sales Share by Region (2012-2017)
Figure Sales Market Share of Human Somatotropin by Region (2012-2017)
Figure EMEA Human Somatotropin Sales Market Share in 2016
Table EMEA Human Somatotropin Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Human Somatotropin Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Human Somatotropin by Region (2012-2017)
Figure EMEA Human Somatotropin Revenue Market Share Regions in 2016
Table EMEA Human Somatotropin Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Human Somatotropin Revenue and Growth Rate (2012-2017)
Table Europe Human Somatotropin Sales (K Pcs) by Type (2012-2017)
Table Europe Human Somatotropin Market Share by Type (2012-2017)
Figure Europe Human Somatotropin Market Share by Type in 2016
Table Europe Human Somatotropin Sales (K Pcs) by Application (2012-2017)
Table Europe Human Somatotropin Market Share by Application (2012-2017)
Figure Europe Human Somatotropin Market Share by Application in 2016
Table Europe Human Somatotropin Sales (K Pcs) by Countries (2012-2017)
Table Europe Human Somatotropin Sales Market Share by Countries (2012-2017)
Figure Europe Human Somatotropin Sales Market Share by Countries (2012-2017)
Figure Europe Human Somatotropin Sales Market Share by Countries in 2016
Table Europe Human Somatotropin Revenue (Million USD) by Countries (2012-2017)
Table Europe Human Somatotropin Revenue Market Share by Countries (2012-2017)
Figure Europe Human Somatotropin Revenue Market Share by Countries (2012-2017)
Figure Europe Human Somatotropin Revenue Market Share by Countries in 2016
Figure Germany Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Human Somatotropin Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Human Somatotropin Sales (K Pcs) by Type (2012-2017)
Table Middle East Human Somatotropin Market Share by Type (2012-2017)
Figure Middle East Human Somatotropin Market Share by Type (2012-2017)
Table Middle East Human Somatotropin Sales (K Pcs) by Applications (2012-2017)
Table Middle East Human Somatotropin Market Share by Applications (2012-2017)
Figure Middle East Human Somatotropin Sales Market Share by Application in 2016
Table Middle East Human Somatotropin Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Human Somatotropin Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Human Somatotropin Sales Volume Market Share by Countries in 2016
Table Middle East Human Somatotropin Revenue (Million USD) by Countries (2012-2017)
Table Middle East Human Somatotropin Revenue Market Share by Countries (2012-2017)
Figure Middle East Human Somatotropin Revenue Market Share by Countries (2012-2017)
Figure Middle East Human Somatotropin Revenue Market Share by Countries in 2016
Figure Saudi Arabia Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Human Somatotropin Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Human Somatotropin Sales (K Pcs) by Type (2012-2017)
Table Africa Human Somatotropin Sales Market Share by Type (2012-2017)
Figure Africa Human Somatotropin Sales Market Share by Type (2012-2017)
Figure Africa Human Somatotropin Sales Market Share by Type in 2016
Table Africa Human Somatotropin Sales (K Pcs) by Application (2012-2017)
Table Africa Human Somatotropin Sales Market Share by Application (2012-2017)
Figure Africa Human Somatotropin Sales Market Share by Application (2012-2017)
Table Africa Human Somatotropin Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Human Somatotropin Sales Market Share by Countries (2012-2017)
Figure Africa Human Somatotropin Sales Market Share by Countries (2012-2017)
Figure Africa Human Somatotropin Sales Market Share by Countries in 2016
Table Africa Human Somatotropin Revenue (Million USD) by Countries (2012-2017)
Table Africa Human Somatotropin Revenue Market Share by Countries (2012-2017)
Figure Africa Human Somatotropin Revenue Market Share by Countries (2012-2017)
Figure Africa Human Somatotropin Revenue Market Share by Countries in 2016
Figure South Africa Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Table Novo Nordisk Human Somatotropin Basic Information List
Table Novo Nordisk Human Somatotropin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novo Nordisk Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novo Nordisk Human Somatotropin Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Human Somatotropin Revenue Market Share in EMEA (2012-2017)
Table Pfizer Human Somatotropin Basic Information List
Table Pfizer Human Somatotropin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Human Somatotropin Sales Market Share in EMEA (2012-2017)
Figure Pfizer Human Somatotropin Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Human Somatotropin Basic Information List
Table Eli Lilly Human Somatotropin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eli Lilly Human Somatotropin Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Human Somatotropin Revenue Market Share in EMEA (2012-2017)
Table Merck Serono Human Somatotropin Basic Information List
Table Merck Serono Human Somatotropin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Serono Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Merck Serono Human Somatotropin Sales Market Share in EMEA (2012-2017)
Figure Merck Serono Human Somatotropin Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Human Somatotropin Basic Information List
Table F. Hoffmann-La Roche Human Somatotropin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Human Somatotropin Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Human Somatotropin Revenue Market Share in EMEA (2012-2017)
Table Ferring Pharmaceuticals Human Somatotropin Basic Information List
Table Ferring Pharmaceuticals Human Somatotropin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ferring Pharmaceuticals Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Ferring Pharmaceuticals Human Somatotropin Sales Market Share in EMEA (2012-2017)
Figure Ferring Pharmaceuticals Human Somatotropin Revenue Market Share in EMEA (2012-2017)
Table GeneScience Pharmaceuticals Human Somatotropin Basic Information List
Table GeneScience Pharmaceuticals Human Somatotropin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GeneScience Pharmaceuticals Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure GeneScience Pharmaceuticals Human Somatotropin Sales Market Share in EMEA (2012-2017)
Figure GeneScience Pharmaceuticals Human Somatotropin Revenue Market Share in EMEA (2012-2017)
Table Ipsen Human Somatotropin Basic Information List
Table Ipsen Human Somatotropin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ipsen Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Ipsen Human Somatotropin Sales Market Share in EMEA (2012-2017)
Figure Ipsen Human Somatotropin Revenue Market Share in EMEA (2012-2017)
Table LG Life Sciences Human Somatotropin Basic Information List
Table LG Life Sciences Human Somatotropin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure LG Life Sciences Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure LG Life Sciences Human Somatotropin Sales Market Share in EMEA (2012-2017)
Figure LG Life Sciences Human Somatotropin Revenue Market Share in EMEA (2012-2017)
Table Sandoz International Human Somatotropin Basic Information List
Table Sandoz International Human Somatotropin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sandoz International Human Somatotropin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sandoz International Human Somatotropin Sales Market Share in EMEA (2012-2017)
Figure Sandoz International Human Somatotropin Revenue Market Share in EMEA (2012-2017)
Table Anhui Anke Biotechnology Human Somatotropin Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Somatotropin
Figure Manufacturing Process Analysis of Human Somatotropin
Figure Human Somatotropin Industrial Chain Analysis
Table Raw Materials Sources of Human Somatotropin Major Manufacturers in 2016
Table Major Buyers of Human Somatotropin
Table Distributors/Traders List
Figure EMEA Human Somatotropin Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Human Somatotropin Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Human Somatotropin Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Human Somatotropin Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Human Somatotropin Sales Market Share Forecast by Region (2017-2022)
Table EMEA Human Somatotropin Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Human Somatotropin Revenue Market Share Forecast by Region (2017-2022)
Table Europe Human Somatotropin Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Human Somatotropin Sales Market Share Forecast by Countries (2017-2022)
Table Europe Human Somatotropin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Human Somatotropin Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Human Somatotropin Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Human Somatotropin Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Human Somatotropin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Human Somatotropin Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Human Somatotropin Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Human Somatotropin Sales Market Share Forecast by Countries (2017-2022)
Table Africa Human Somatotropin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Human Somatotropin Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Human Somatotropin Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Human Somatotropin Sales Market Share Forecast by Type (2017-2022)
Table EMEA Human Somatotropin Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Human Somatotropin Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources